1985
DOI: 10.1097/00005176-198512000-00012
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity Mechanisms of Wheat and Other Cereals in Celiac Disease and Related Enteropathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

1988
1988
2004
2004

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 31 publications
(13 citation statements)
references
References 0 publications
0
13
0
Order By: Relevance
“…It is not clear whether these discrepancies depend on the use in some studies of biochemical markers versus the use in other studies of morphological and morphometric parameters to assess the status of the intestinal mucosa or rather on the possibility that for the coeliac mucosa in remission there is a time lag before in vitro toxic effects of gliadin peptides may show up [93] which depends on the "degree of remission" of the mucosa specimens tested. The latter hypothesis is also supported by the fact that when the data of Falchuk et al [73] showing the absence of effects of gluten peptides on treated coeliac mucosa, were re-evaluated by Auricchio et al [93] it appeared that specimens with a lower initial alkaline phosphatase level (i. e. less recovered) were susceptible to toxic effects of gluten peptides, whereas those with a higher initial level of alkaline phosphatase (i. e. more recovered) were not, although all were derived from a mucosa in remission.…”
Section: Studies On Cereal Peptides With Cultured Intestinal Biopsiesmentioning
confidence: 99%
See 2 more Smart Citations
“…It is not clear whether these discrepancies depend on the use in some studies of biochemical markers versus the use in other studies of morphological and morphometric parameters to assess the status of the intestinal mucosa or rather on the possibility that for the coeliac mucosa in remission there is a time lag before in vitro toxic effects of gliadin peptides may show up [93] which depends on the "degree of remission" of the mucosa specimens tested. The latter hypothesis is also supported by the fact that when the data of Falchuk et al [73] showing the absence of effects of gluten peptides on treated coeliac mucosa, were re-evaluated by Auricchio et al [93] it appeared that specimens with a lower initial alkaline phosphatase level (i. e. less recovered) were susceptible to toxic effects of gluten peptides, whereas those with a higher initial level of alkaline phosphatase (i. e. more recovered) were not, although all were derived from a mucosa in remission.…”
Section: Studies On Cereal Peptides With Cultured Intestinal Biopsiesmentioning
confidence: 99%
“…It is not clear whether these discrepancies depend on the use in some studies of biochemical markers versus the use in other studies of morphological and morphometric parameters to assess the status of the intestinal mucosa or rather on the possibility that for the coeliac mucosa in remission there is a time lag before in vitro toxic effects of gliadin peptides may show up [93] which depends on the "degree of remission" of the mucosa specimens tested. The latter hypothesis is also supported by the fact that when the data of Falchuk et al [73] showing the absence of effects of gluten peptides on treated coeliac mucosa, were re-evaluated by Auricchio et al [93] it appeared that specimens with a lower initial alkaline phosphatase level (i. e. less recovered) were susceptible to toxic effects of gluten peptides, whereas those with a higher initial level of alkaline phosphatase (i. e. more recovered) were not, although all were derived from a mucosa in remission. Moreover, the fact that, when mucosal tissue samples from patients with active and inactive coeliac disease were co-cultured, gliadin affected both cultures, does not necessarily imply that gliadin peptides are not directly toxic to epithelial cells of coeliac mucosa and require the activation of an endogenous effector mechanism diffusible through the culture medium, [66], but may also depend on a binding of gliadin peptides to coeliac mucosa in remission resulting in a cytostatic effect making epithelial cells more susceptible to the effects of killer cells (e. g., lymphocytes) coming from the atrophic mucosa fragments.…”
Section: Studies On Cereal Peptides With Cultured Intestinal Biopsiesmentioning
confidence: 99%
See 1 more Smart Citation
“…A 33-mer peptide was shown to be a potent inducer of gutderived human T-cell lines in 14 of 14 CS patients (40). Other peptides, such as fragment 31-43 of A-gliadin, caused an inflammatory response of the small intestinal mucosa (5,8,36) without a T-cell-mediated response (35). The large proportion and location of proline residues in the amino acid sequences of these toxic peptides make them extremely resistant to further proteolysis (2,11,27).…”
mentioning
confidence: 99%
“…Among these systems, agglutination of in vitro cultured human myelogenous leukemia K 562(S) cells proved to be a suitable model for detection of toxic components (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21). In fact, very low concentrations of peptic-tryptic (PT) digests of gliadins and prolamins from rye, barley, and oat were shown to be able to agglutinate the K 562(S) cells, whereas nontoxic peptides (albumin and globulin of wheat and prolamins from rice and maize) proved to be inactive.…”
Section: Introductionmentioning
confidence: 99%